Cargando…

Similarities and differences in the biotransformation and transcriptomic responses of Caenorhabditis elegans and Haemonchus contortus to five different benzimidazole drugs

We have undertaken a detailed analysis of the biotransformation of five of the most therapeutically important benzimidazole anthelmintics - albendazole (ABZ), mebendazole (MBZ), thiabendazole (TBZ), oxfendazole (OxBZ) and fenbendazole (FBZ) - in Caenorhabditis elegans and the ruminant parasite Haemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Stasiuk, S.J., MacNevin, G., Workentine, M.L., Gray, D., Redman, E., Bartley, D., Morrison, A., Sharma, N., Colwell, D., Ro, D.K., Gilleard, J.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796749/
https://www.ncbi.nlm.nih.gov/pubmed/31542693
http://dx.doi.org/10.1016/j.ijpddr.2019.09.001
_version_ 1783459679215550464
author Stasiuk, S.J.
MacNevin, G.
Workentine, M.L.
Gray, D.
Redman, E.
Bartley, D.
Morrison, A.
Sharma, N.
Colwell, D.
Ro, D.K.
Gilleard, J.S.
author_facet Stasiuk, S.J.
MacNevin, G.
Workentine, M.L.
Gray, D.
Redman, E.
Bartley, D.
Morrison, A.
Sharma, N.
Colwell, D.
Ro, D.K.
Gilleard, J.S.
author_sort Stasiuk, S.J.
collection PubMed
description We have undertaken a detailed analysis of the biotransformation of five of the most therapeutically important benzimidazole anthelmintics - albendazole (ABZ), mebendazole (MBZ), thiabendazole (TBZ), oxfendazole (OxBZ) and fenbendazole (FBZ) - in Caenorhabditis elegans and the ruminant parasite Haemonchus contortus. Drug metabolites were detected by LC-MS/MS analysis in supernatants of C. elegans cultures with a hexose conjugate, most likely glucose, dominating for all five drugs. This work adds to a growing body of evidence that glucose conjugation is a major pathway of xenobiotic metabolism in nematodes and may be a target for enhancement of anthelmintic potency. Consistent with this, we found that biotransformation of albendazole by C. elegans reduced drug potency. Glucose metabolite production by C. elegans was reduced in the presence of the pharmacological inhibitor chrysin suggesting that UDP-glucuronosyl/glucosyl transferase (UGT) enzymes may catalyze benzimidazole glucosidation. Similar glucoside metabolites were detected following ex vivo culture of adult Haemonchus contortus. As a step towards identifying nematode enzymes potentially responsible for benzimidazole biotransformation, we characterised the transcriptomic response to each of the benzimidazole drugs using the C. elegans resistant strain CB3474 ben-1(e1880)III. In the case of albendazole, mebendazole, thiabendazole, and oxfendazole the shared transcriptomic response was dominated by the up-regulation of classical xenobiotic response genes including a shared group of UGT enzymes (ugt-14/25/33/34/37/41/8/9). In the case of fenbendazole, a much greater number of genes were up-regulated, as well as developmental and brood size effects suggesting the presence of secondary drug targets in addition to BEN-1. The transcriptional xenobiotic response of a multiply resistant H. contortus strain UGA/2004 was essentially undetectable in the adult stage but present in the L3 infective stage, albeit more muted than C. elegans. This suggests that xenobiotic responses may be less efficient in stages of parasitic nematodes that reside in the host compared with the free-living stages.
format Online
Article
Text
id pubmed-6796749
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67967492019-10-22 Similarities and differences in the biotransformation and transcriptomic responses of Caenorhabditis elegans and Haemonchus contortus to five different benzimidazole drugs Stasiuk, S.J. MacNevin, G. Workentine, M.L. Gray, D. Redman, E. Bartley, D. Morrison, A. Sharma, N. Colwell, D. Ro, D.K. Gilleard, J.S. Int J Parasitol Drugs Drug Resist Regular Article We have undertaken a detailed analysis of the biotransformation of five of the most therapeutically important benzimidazole anthelmintics - albendazole (ABZ), mebendazole (MBZ), thiabendazole (TBZ), oxfendazole (OxBZ) and fenbendazole (FBZ) - in Caenorhabditis elegans and the ruminant parasite Haemonchus contortus. Drug metabolites were detected by LC-MS/MS analysis in supernatants of C. elegans cultures with a hexose conjugate, most likely glucose, dominating for all five drugs. This work adds to a growing body of evidence that glucose conjugation is a major pathway of xenobiotic metabolism in nematodes and may be a target for enhancement of anthelmintic potency. Consistent with this, we found that biotransformation of albendazole by C. elegans reduced drug potency. Glucose metabolite production by C. elegans was reduced in the presence of the pharmacological inhibitor chrysin suggesting that UDP-glucuronosyl/glucosyl transferase (UGT) enzymes may catalyze benzimidazole glucosidation. Similar glucoside metabolites were detected following ex vivo culture of adult Haemonchus contortus. As a step towards identifying nematode enzymes potentially responsible for benzimidazole biotransformation, we characterised the transcriptomic response to each of the benzimidazole drugs using the C. elegans resistant strain CB3474 ben-1(e1880)III. In the case of albendazole, mebendazole, thiabendazole, and oxfendazole the shared transcriptomic response was dominated by the up-regulation of classical xenobiotic response genes including a shared group of UGT enzymes (ugt-14/25/33/34/37/41/8/9). In the case of fenbendazole, a much greater number of genes were up-regulated, as well as developmental and brood size effects suggesting the presence of secondary drug targets in addition to BEN-1. The transcriptional xenobiotic response of a multiply resistant H. contortus strain UGA/2004 was essentially undetectable in the adult stage but present in the L3 infective stage, albeit more muted than C. elegans. This suggests that xenobiotic responses may be less efficient in stages of parasitic nematodes that reside in the host compared with the free-living stages. Elsevier 2019-09-09 /pmc/articles/PMC6796749/ /pubmed/31542693 http://dx.doi.org/10.1016/j.ijpddr.2019.09.001 Text en © 2019 Published by Elsevier Ltd on behalf of Australian Society for Parasitology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Stasiuk, S.J.
MacNevin, G.
Workentine, M.L.
Gray, D.
Redman, E.
Bartley, D.
Morrison, A.
Sharma, N.
Colwell, D.
Ro, D.K.
Gilleard, J.S.
Similarities and differences in the biotransformation and transcriptomic responses of Caenorhabditis elegans and Haemonchus contortus to five different benzimidazole drugs
title Similarities and differences in the biotransformation and transcriptomic responses of Caenorhabditis elegans and Haemonchus contortus to five different benzimidazole drugs
title_full Similarities and differences in the biotransformation and transcriptomic responses of Caenorhabditis elegans and Haemonchus contortus to five different benzimidazole drugs
title_fullStr Similarities and differences in the biotransformation and transcriptomic responses of Caenorhabditis elegans and Haemonchus contortus to five different benzimidazole drugs
title_full_unstemmed Similarities and differences in the biotransformation and transcriptomic responses of Caenorhabditis elegans and Haemonchus contortus to five different benzimidazole drugs
title_short Similarities and differences in the biotransformation and transcriptomic responses of Caenorhabditis elegans and Haemonchus contortus to five different benzimidazole drugs
title_sort similarities and differences in the biotransformation and transcriptomic responses of caenorhabditis elegans and haemonchus contortus to five different benzimidazole drugs
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796749/
https://www.ncbi.nlm.nih.gov/pubmed/31542693
http://dx.doi.org/10.1016/j.ijpddr.2019.09.001
work_keys_str_mv AT stasiuksj similaritiesanddifferencesinthebiotransformationandtranscriptomicresponsesofcaenorhabditiselegansandhaemonchuscontortustofivedifferentbenzimidazoledrugs
AT macneving similaritiesanddifferencesinthebiotransformationandtranscriptomicresponsesofcaenorhabditiselegansandhaemonchuscontortustofivedifferentbenzimidazoledrugs
AT workentineml similaritiesanddifferencesinthebiotransformationandtranscriptomicresponsesofcaenorhabditiselegansandhaemonchuscontortustofivedifferentbenzimidazoledrugs
AT grayd similaritiesanddifferencesinthebiotransformationandtranscriptomicresponsesofcaenorhabditiselegansandhaemonchuscontortustofivedifferentbenzimidazoledrugs
AT redmane similaritiesanddifferencesinthebiotransformationandtranscriptomicresponsesofcaenorhabditiselegansandhaemonchuscontortustofivedifferentbenzimidazoledrugs
AT bartleyd similaritiesanddifferencesinthebiotransformationandtranscriptomicresponsesofcaenorhabditiselegansandhaemonchuscontortustofivedifferentbenzimidazoledrugs
AT morrisona similaritiesanddifferencesinthebiotransformationandtranscriptomicresponsesofcaenorhabditiselegansandhaemonchuscontortustofivedifferentbenzimidazoledrugs
AT sharman similaritiesanddifferencesinthebiotransformationandtranscriptomicresponsesofcaenorhabditiselegansandhaemonchuscontortustofivedifferentbenzimidazoledrugs
AT colwelld similaritiesanddifferencesinthebiotransformationandtranscriptomicresponsesofcaenorhabditiselegansandhaemonchuscontortustofivedifferentbenzimidazoledrugs
AT rodk similaritiesanddifferencesinthebiotransformationandtranscriptomicresponsesofcaenorhabditiselegansandhaemonchuscontortustofivedifferentbenzimidazoledrugs
AT gilleardjs similaritiesanddifferencesinthebiotransformationandtranscriptomicresponsesofcaenorhabditiselegansandhaemonchuscontortustofivedifferentbenzimidazoledrugs